← Leaderboards
Jack C. Yalowich
Ohio State University
$4,212,052
Attributed
$5,093,709
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $647.3K · FY2007–23$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,093,709 · 3
By mechanism
R01$5,093,709 · 3
Top collaborators
- Terry S Elton5 shared
Most similar at Ohio State University
Same institution · by research overlap
- Terry S Elton$3,572,815
- Martin D. Caffrey$3,224,687
- Ramiro Garzon$6,835,986
Others in their field
Top investigators on “Etoposide”
- Gregory H Reaman · National Childhood Cancer Foundation$18,332,016
- Charles A Coltman · Southwest Oncology Group$18,209,974
- Sharon B. Murphy · Northwestern University$7,718,936
- David Macpherson · Carnegie Institution Of Washington, D.C.$7,200,975
- Neil Osheroff · Vanderbilt University$6,364,254
- John L. Nitiss · University Of Illinois At Chicago$5,150,188
Research focus
EtoposideDna DamageProductionAttenuatedDna Strand BreakCellsLeukemiaMediatingEnzymesComplexSiteAntineoplastic AgentsAscorbateNeoplastic CellOligonucleotidesProteinsClinical EfficacySouthern BlottingDna TopoisomerasesDeoxyguanosineEventAntioxidantsCd34 GeneDihydrolipoate
Grant awards (18)
Novel Topoisomerase II alpha isoform as a drug resistance determinant$349,713
R01 · FY2023 · CA · contact PI
Novel Topoisomerase II alpha isoform as a drug resistance determinant$349,713
R01 · FY2022 · CA · contact PI
Novel Topoisomerase II alpha isoform as a drug resistance determinant$356,850
R01 · FY2021 · CA · contact PI
Novel Topoisomerase II alpha isoform as a drug resistance determinant$356,850
R01 · FY2020 · CA · contact PI
Novel Topoisomerase II alpha isoform as a drug resistance determinant$350,189
R01 · FY2019 · CA · contact PI
Mechanisms and Prevention of Etoposide-Induced Leukemia$285,209
R01 · FY2011 · CA · contact PI
Mechanisms and Prevention of Etoposide-Induced Leukemia$229,810
R01 · FY2010 · CA · contact PI
Mechanisms and Prevention of Etoposide-Induced Leukemia$79,212
R01 · FY2010 · CA · contact PI
Mechanisms and Prevention of Etoposide-Induced Leukemia$317,802
R01 · FY2009 · CA · contact PI
Mechanisms and Prevention of Etoposide-Induced Leukemia$237,195
R01 · FY2009 · CA · contact PI
Mechanisms and Prevention of Etoposide-Induced Leukemia$92,319
R01 · FY2009 · CA · contact PI
Mechanisms and Prevention of Etoposide-Induced Leukemia$317,699
R01 · FY2008 · CA · contact PI
Mechanisms and Prevention of Etoposide-Induced Leukemia$317,600
R01 · FY2007 · CA · contact PI
Mechanisms and prevention of etoposide induced leukemia$309,175
R01 · FY2004 · CA
Mechanisms and prevention of etoposide induced leukemia$309,521
R01 · FY2003 · CA
Mechanisms and prevention of etoposide induced leukemia$310,559
R01 · FY2002 · CA
Mechanisms and prevention of etoposide induced leukemia$311,250
R01 · FY2001 · CA
MECHANISMS OF ACTION AND RESISTANCE TO ICRF187$213,043
R01 · FY2000 · CA